Financial insights of CLOV

MyFinsight

For the quarter ending 2025-09-30, CLOV made $496,650K in revenue. -$24,083K in net income. Net profit margin of -4.85%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2024-09-30	2024-06-30
Total revenues	496,650	477,620	330,986	356,260
Net medical claims incurred	423,473	377,992	249,774	248,347
Salaries and benefits	48,195	61,309	54,995	55,499
General and administrative expenses	48,953	48,484	35,201	44,424
Depreciation and amortization	406	394	339	330
Restructuring (recoveries) costs	0	0	-538	473
Total operating expenses	521,027	488,179	339,771	349,073
Loss from continuing operations	-24,377	-10,559	-8,785	7,187
Change in fair value of warrants	0	19	-	17
Loss on investment	0	0	-	-
Net loss from continuing operations	-24,377	-10,578	-8,785	7,170
Net (loss) income from discontinued operations	0	0	-370	238
Net loss	-24,377	-10,578	-9,155	7,408
Net unrealized gain on available-for-sale investments	294	251	3,111	301
Comprehensive loss	-24,083	-10,327	-6,044	7,709

Basic weighted average number of class a and class b common shares and common share equivalents outstanding (in shares)	512,743,521	509,043,210	490,180,103	487,483,087
Diluted weighted average number of class a and class b common shares and common share equivalents outstanding (in shares)	512,743,521	509,043,210	490,180,103	495,179,955